We are delighted to kick-start 2021 with the exciting news that Roche, a global leader in pharmaceuticals and diagnostics, has become the first healthcare company to join Manufacture 2030.
Roche has been committed to improving lives since it was founded in 1896. Today, Roche is the world’s leading biotech company and a frontrunner in personal healthcare, creating innovative medicines and diagnostic tests that help millions of patients globally.
Sustainability is fully embedded into Roche’s strategy. Roche’s main contribution to society is lasting innovation. Roche also strives to manage its environmental, social and economic impact to create long-term value for society while achieving sustainable economic growth. This includes minimising its impact on the environment, maintaining relationships built on trust with its key stakeholders and providing a great workplace for its employees.
The responsible management of supply throughout the value chain is a central theme. One of the key ways Roche’s Procurement function supports this is by collaborating with suppliers to reduce environmental impacts, and the new partnership with Manufacture 2030 is part of this commitment.
Launching in phases from mid-February, the 3-year partnership will start by reaching out to the Roche supply base across Diagnostics, Diabetes Care and Pharmaceuticals.
Kelley Hinds, Global Head of Sustainability & Risk at Roche Global Procurement, said:
“We have a tremendous opportunity, through our supplier relationships and responsible procurement practices, to tackle some of the world’s biggest challenges. Our new partnership with Manufacture 2030 will focus on supporting our suppliers to improve at scale, which in turn helps Roche make progress against our Scope 3 emissions reduction targets. We believe in the power of collaboration and welcome any opportunity to increase positive impact by working together.”
Martin Chilcott, Founder and CEO at Manufacture 2030, commented:
“We are delighted to be launching a new partnership with Roche, reducing environmental impacts across their global supply chain. Roche are a world leader, both in terms of their expertise in pharmaceuticals and diagnostics, but also as a pioneer of responsible business practices. They also have a track record of working with innovative companies who are pushing boundaries, and we look forward to launching our unique approach in support of Roche’s commitment to reduce supplier emissions.”